SecBot SecBot
SECBOTREPLAY Home › Report › XERS

XERS · Dr

Xeris Biopharma Holdings, Inc. · 3 filed Jul 2, 2026 at 17:59 ET

At the news

NEUTRALIMPACT 3/10

3 filed Jul 2, 2026 at 17:59 ET

Dr. Nerissa Kreher has been appointed as a director of Xeris Biopharma Holdings, Inc., effective July 1, 2026, and filed a Form 3 initial statement of beneficial ownership. This is a routine administrative filing with no disclosure of actual holdings or material financial impact.

  • Dr. Nerissa Kreher appointed as director, effective 2026-07-01
  • Form 3 filed to report initial beneficial ownership (no ownership amounts disclosed)
  • Power of Attorney granted to John Shannon, Beth Hecht, and Steve Pieper for Section 16 filings

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access